Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
06/2010
06/15/2010US7737171 Uses of 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRIS
06/15/2010US7737170 Uses of 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRIS
06/15/2010US7737166 such as 2-tert-Butyl-7-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]-5-methyl-6-phenyl-1,3-benzoxazole-4-carbonitrile hydrochloride, a 1,6-beta-glucan synthetase inhibitor having potent growth inhibition, used treating a fungal infections; fungicides
06/15/2010US7737153 Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
06/15/2010US7737152 6-carboaryl-oxy-pyrazin-2-yl-carboaryl-amines and compositions comprising said compounds
06/15/2010US7737142 (Thio) carbamoyl-cyclohexane derivatives as D3/D2 receptor antagonists
06/15/2010US7737141 Prodrug of cinnamide compound
06/15/2010CA2521647C Novel hydroxamates as therapeutic agents
06/15/2010CA2495577C Novel benzoimidazole derivatives useful as antiproliferative agents
06/15/2010CA2328440C Heterocyclically substituted amides used as calpain inhibitors
06/10/2010WO2010065717A1 Morpholinone compounds as factor ixa inhibitors
06/10/2010WO2010064707A1 2h-chromene compound and derivative thereof
06/10/2010WO2010064597A1 Piperidine derivative
06/10/2010WO2010063666A1 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives
06/10/2010WO2010063663A1 N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0]hept-4-yl] methyl}-2-heteroarylamine derivatives and uses thereof
06/10/2010WO2010063662A1 N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0] hept-4-yl] methyl}-2-heteroarylamine derivatives and uses thereof
06/10/2010WO2010027875A3 Compounds that modulate intracellular calcium
06/10/2010WO2010021934A3 Azaindole inhibitors of iap
06/10/2010WO2010013835A3 Solid pharmaceutical composition
06/10/2010WO2009058267A3 Benzomorpholine derivatives and methods of use
06/10/2010US20100145064 Method for the preparation of zolmitriptan
06/10/2010US20100145050 Orthogonally fixed compounds for electrooptical applications
06/10/2010US20100145048 Compounds for the treatment of inflammatory disorders
06/10/2010US20100145042 Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
06/10/2010US20100145041 Thiazolyl-dihydro-quinazoline compounds and processes for preparing same
06/10/2010US20100145040 Benzazepine Derivatives For The Treatment of Neurological Disorders
06/10/2010US20100144798 Modulators of ATP-Binding Cassette Transporters
06/10/2010US20100144797 Isoxazoline-substituted benzamide compound and pest control agent
06/10/2010US20100144778 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
06/10/2010US20100144768 Kinase inhibitor compounds
06/10/2010US20100144747 1h-quinaz0line-2,4-diones
06/10/2010US20100144735 Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
06/10/2010US20100144734 1, 2, 3-Triazole derivatives as new cannabinoid-1 receptor antagonists
06/10/2010US20100144733 Compounds, compositions and methods comprising heteroaromatic derivatives
06/10/2010US20100144732 Pyrimidine kinase inhibitors
06/10/2010US20100144731 Novel Biccyclic Compounds As GATA Modulators
06/10/2010US20100144730 Pyridinonyl pdk1 inhibitors
06/10/2010US20100144729 Coumarin derivatives
06/10/2010US20100144724 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives
06/10/2010US20100144723 1-(biphenyl-4-ylmethyl)imidazolidine-2,4-dione
06/10/2010US20100144722 Novel heterocyclic compounds as gata modulators
06/10/2010US20100144713 6-and 7-amino isoquinoline compounds and methods for making and using the same
06/10/2010US20100144712 Triazole derivatives having antifungal activity, method for the preparation thereof, and pharmaceutical composition comprising the same
06/10/2010US20100144707 Pharmacokinetically improved compounds
06/10/2010US20100144706 Compounds
06/10/2010US20100144705 Egfr kinase knockdown via electrophilically enhanced inhibitors
06/10/2010US20100144702 Indole compound
06/10/2010US20100144649 Compounds for enzyme inhibition
06/10/2010US20100144588 Proton acceptor iminium/carbocation-type coupling agents
06/10/2010US20100143917 Fluorescent chemical compounds having high selectivity for double stranded dna, and methods for their use
06/10/2010US20100143299 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections
06/10/2010US20100143295 Quinazoline inhibitors of egfr tyrosine kinase
06/10/2010CA2745433A1 N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0]hept-4-yl] methyl}-2-heteroarylamine derivatives and uses thereof
06/10/2010CA2745420A1 N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0] hept-4-yl] methyl}-2-heteroarylamine derivatives and uses thereof
06/10/2010CA2745356A1 2h-chromene compound and derivative thereof
06/10/2010CA2745121A1 Morpholinone compounds as factor ixa inhibitors
06/10/2010CA2744914A1 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives
06/09/2010EP2194046A1 Triazolone derivative
06/09/2010EP2193129A1 6-pyrimidinyl-pyrimid-2-one derivative
06/09/2010EP2193125A2 Oxadiazole derivatives
06/09/2010EP2193119A1 4-(4-pyridinyl)-benzamides and their use as rock activity modulators
06/09/2010EP2193118A2 Piperidine and piperazine derivatives for treating tumours
06/09/2010EP2193112A1 Electroluminescent device
06/09/2010EP2192900A2 Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators
06/09/2010EP1711494B1 Aryl substituted heterocycles, method for production and use thereof as medicaments
06/09/2010EP1335907B1 Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor
06/09/2010CN1956984B 1,3,4-oxadiazol-2-ones as PPAR-delta modulators
06/09/2010CN1852712B Dual NK1/NK3 antagonists for treating schizophrenia
06/09/2010CN1784391B Quinazolines useful as modulators of ion channels
06/09/2010CN1694874B Benzodiazepine derivatives and pharmaceutical compositions containing them
06/09/2010CN101730695A Aminoacyl prodrugs as an active pharmaceutical ingredient for thromboembolic disorders
06/09/2010CN101730694A Substituted deuterium enriched thiophenes for the treatment of hypertension
06/09/2010CN101730692A Pyridazinone derivatives useful as glucan synthase inhibitors
06/09/2010CN101730680A 4' substituted compounds having 5-ht6 receptor affinity
06/09/2010CN101723941A '1,2,4' oxadiazoles as modulators of metabotropic glutamate receptor-5
06/09/2010CN101723900A Cinnamide compound
06/09/2010CN101220023B Coordination polymer type ion exchange material, preparation and application thereof
06/08/2010US7732605 inducing cyclization of an alpha -keto acid with an acid catalyst; N-2-oxo-propanoyl-L-phenylalanine amide; antitumor activity and selectivity
06/08/2010US7732600 Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors
06/08/2010US7732597 Prepared by acetylating (S)-N-[[3-[3-fluoro-4-[4-morpholinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl]amine in a solvent, optionally in presence of an organic base to form linezolid, seeding reaction mixture, and isolating linezolid form III; antibacterial agent; thermally stable
06/08/2010US7732449 preferential enzyme Inhibitors such as 4-(4-Acetyl-piperazin-1-yl)-2-(R)-cyclohexylmethyl-N-[1-(S)-methyl-2-(4-trifluoromethoxy-phenylamino)-ethyl]-4-oxo-butyramide, used for the treatment of inflammation, arthritis and atherosclerosis
06/08/2010US7732146 Method for screening an agent that modulates activity of macrophage migration inhibitory factor
06/08/2010CA2479831C Benzofuran derivative
06/08/2010CA2388063C Cytotoxic agents comprising taxanes and their therapeutic use
06/03/2010WO2010062265A1 Therapeutic macrolide compounds and their use
06/03/2010WO2010061971A1 Pyridine-3-carboxyamide derivative
06/03/2010WO2010061282A1 Derivatives of [(3-hydroxy-4 pyron-2-yl)methyl]-amine and use thereof as anti-neoplastic drugs
06/03/2010WO2010060703A1 3-(benzylamino)-pyrrolidine derivatives and their use as nk-3 receptor antagonists
06/03/2010WO2010014257A3 Tetrahydropyridinyl and dihydropyrrolyl compounds and the use thereof
06/03/2010WO2010005692A4 Insecticidal cyclic carbonyl amidines
06/03/2010WO2009158257A3 Fungicidal pyridines
06/03/2010WO2009154300A3 Heterocyclic compound and use thereof
06/03/2010WO2009061652A8 Compounds which modulate the cb2 receptor
06/03/2010WO2009034396A3 Method and means relating to multiple herbicide resistance in plants
06/03/2010WO2008151303A8 Long wavelength fluorogenic intercellular ion indicators
06/03/2010US20100137606 Novel compound having beta-secretase inhibitory activity
06/03/2010US20100137587 Heterocyclic compound and use thereof
06/03/2010US20100137586 Process for the Preparation of Gefitinib
06/03/2010US20100137469 Aziridine-functional photoactive crosslinking compounds
06/03/2010US20100137372 Isoxazoline compounds and their use in pest control
1 ... 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 ... 647